Zou A P, Fleming J T, Falck J R, Jacobs E R, Gebremedhin D, Harder D R, Roman R J
Department of Physiology, Medical College of Wisconsin, Milwaukee 53226, USA.
Am J Physiol. 1996 May;270(5 Pt 2):F822-32. doi: 10.1152/ajprenal.1996.270.5.F822.
The present study examined the effects of 11,12- and 14,15-epoxyeicosatrienoic acids (EETs) on the diameter of small renal arteries of the rat and assessed their action on K(+)-channel activity in vascular smooth muscle (VSM) cells isolated from these vessels. The R,S-isomer of 11,12-EET (1, 10, and 100 nM) increased the diameter of small renal arteries preconstricted with phenylephrine; however, the S,R-isomer was inactive. Both the R,S- and S,R-isomers of 14,15-EET had little effect on the diameter of these vessels even at a high concentration (100 nM). The vasodilator effect of 11(R),12(S)-EET was attenuated by tetraethylammonium (TEA, 1 mM) and iberiotoxin (100 nM), selective inhibitors of the large-conductance Ca(2+)-activated K+ (KCa) channel. In contrast, apamin (100 nM) and 4-aminopyridine (2 mM), which are inhibitors of other types of K+ channels, had no effect on the vasodilatory effect of 11,12-EET. In patch-clamp experiments, 100 nM racemic 11,12-EET increased outward K+ currents in VSM cells. Addition of the R,S-isomer or racemic 11,12-EET (1-100 nM), but not the S,R-isomer, increased the activity of KCa channel recorded from renal VSM cells with cell-attached patches. However, racemic EET had no effect on this channel when added to the internal (inside-out) or external (outside-out) face of excised membrane patches. These results suggest that 11,12-EET is a potent dilator of small renal arteries and that the R,S-isomer is the active enantiomer. The vasodilator effect of 11,12-EET appears to involve activation of KCa channel.
本研究检测了11,12-和14,15-环氧二十碳三烯酸(EETs)对大鼠肾小动脉直径的影响,并评估了它们对从这些血管分离出的血管平滑肌(VSM)细胞中钾通道活性的作用。11,12-EET的R,S-异构体(1、10和100 nM)可增加用去氧肾上腺素预收缩的肾小动脉直径;然而,S,R-异构体无活性。即使在高浓度(100 nM)下,14,15-EET的R,S-和S,R-异构体对这些血管的直径几乎没有影响。11(R),12(S)-EET的血管舒张作用被大电导钙激活钾(KCa)通道的选择性抑制剂四乙铵(TEA,1 mM)和iberiotoxin(100 nM)减弱。相比之下,其他类型钾通道的抑制剂蜂毒明肽(100 nM)和4-氨基吡啶(2 mM)对11,12-EET的血管舒张作用没有影响。在膜片钳实验中,100 nM外消旋11,12-EET增加了VSM细胞中的外向钾电流。添加R,S-异构体或外消旋11,12-EET(1-100 nM),而不是S,R-异构体,增加了用细胞贴附膜片从肾VSM细胞记录的KCa通道活性。然而,当外消旋EET添加到切除膜片的内表面(内向外)或外表面(外向内)时,对该通道没有影响。这些结果表明,11,12-EET是肾小动脉的有效扩张剂,且R,S-异构体是活性对映体。11,12-EET的血管舒张作用似乎涉及KCa通道的激活。